Cargando…

Taking Charge After Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Randomized Controlled Feasibility Trial of a Psychologically Informed Self-Management Intervention

PURPOSE: Few interventions improve outcomes for people with Chronic Obstructive Pulmonary Disease (COPD), particularly higher risk groups such as those admitted to hospital with an acute exacerbation of COPD (AECOPD). The aim of the study was to test the feasibility and acceptability of a modified v...

Descripción completa

Detalles Bibliográficos
Autores principales: Levack, William M M, Weatherall, Mark, McNaughton, Harry K, McNaughton, Amanda A, Hobman, Anna, Jones, Bernadette, Ingham, Tristram R, Fingleton, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024904/
https://www.ncbi.nlm.nih.gov/pubmed/36945705
http://dx.doi.org/10.2147/COPD.S393644
_version_ 1784909211517321216
author Levack, William M M
Weatherall, Mark
McNaughton, Harry K
McNaughton, Amanda A
Hobman, Anna
Jones, Bernadette
Ingham, Tristram R
Fingleton, James
author_facet Levack, William M M
Weatherall, Mark
McNaughton, Harry K
McNaughton, Amanda A
Hobman, Anna
Jones, Bernadette
Ingham, Tristram R
Fingleton, James
author_sort Levack, William M M
collection PubMed
description PURPOSE: Few interventions improve outcomes for people with Chronic Obstructive Pulmonary Disease (COPD), particularly higher risk groups such as those admitted to hospital with an acute exacerbation of COPD (AECOPD). The aim of the study was to test the feasibility and acceptability of a modified version of the Take Charge program in people after AECOPD and to determine the potential to improve self-reported limitations, health-related quality of life and reduce future hospitalizations. PATIENTS AND METHODS: A prospective, parallel group randomized trial with blinded endpoint assessment. Participants had been discharged from hospital with a diagnosis of AECOPD and were randomized to receive either a single 60–90 minute session of “Take Charge for COPD” from a trained facilitator in their own home or usual care. Take Charge is a “talking therapy” that encourages a sense of purpose, autonomy, mastery, and connectedness with others. The primary outcome was the rate of moderate or severe episodes of AECOPD in the subsequent 12 months. RESULTS: Fifty-six people were randomized (study target 60): predominantly European (71%), female (61%), older (mean [SD] age 70 [11] years), and non-smokers (89%). Charlson Comorbidity Index mean (SD) score was 2.3 (1.6) indicating mild to moderate comorbidity severity. There were 85 moderate or severe AECOPD episodes in the 12 months after the index admission for the Take Charge participants and 84 episodes in the control group (relative rate 0.93; 95% confidence interval (CI) 0.69 to 1.26). COPD Clinical Questionnaire (CCQ) scores were significantly lower (better) in the Take Charge group (mean difference −1.26; 95% CI −2.06 to −0.45). CONCLUSION: The Take Charge intervention proved feasible with a population of people recently discharged from hospital with AECOPD. The direction of change in the primary outcome and some secondary outcomes suggest that an adequately powered study is justified.
format Online
Article
Text
id pubmed-10024904
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-100249042023-03-20 Taking Charge After Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Randomized Controlled Feasibility Trial of a Psychologically Informed Self-Management Intervention Levack, William M M Weatherall, Mark McNaughton, Harry K McNaughton, Amanda A Hobman, Anna Jones, Bernadette Ingham, Tristram R Fingleton, James Int J Chron Obstruct Pulmon Dis Original Research PURPOSE: Few interventions improve outcomes for people with Chronic Obstructive Pulmonary Disease (COPD), particularly higher risk groups such as those admitted to hospital with an acute exacerbation of COPD (AECOPD). The aim of the study was to test the feasibility and acceptability of a modified version of the Take Charge program in people after AECOPD and to determine the potential to improve self-reported limitations, health-related quality of life and reduce future hospitalizations. PATIENTS AND METHODS: A prospective, parallel group randomized trial with blinded endpoint assessment. Participants had been discharged from hospital with a diagnosis of AECOPD and were randomized to receive either a single 60–90 minute session of “Take Charge for COPD” from a trained facilitator in their own home or usual care. Take Charge is a “talking therapy” that encourages a sense of purpose, autonomy, mastery, and connectedness with others. The primary outcome was the rate of moderate or severe episodes of AECOPD in the subsequent 12 months. RESULTS: Fifty-six people were randomized (study target 60): predominantly European (71%), female (61%), older (mean [SD] age 70 [11] years), and non-smokers (89%). Charlson Comorbidity Index mean (SD) score was 2.3 (1.6) indicating mild to moderate comorbidity severity. There were 85 moderate or severe AECOPD episodes in the 12 months after the index admission for the Take Charge participants and 84 episodes in the control group (relative rate 0.93; 95% confidence interval (CI) 0.69 to 1.26). COPD Clinical Questionnaire (CCQ) scores were significantly lower (better) in the Take Charge group (mean difference −1.26; 95% CI −2.06 to −0.45). CONCLUSION: The Take Charge intervention proved feasible with a population of people recently discharged from hospital with AECOPD. The direction of change in the primary outcome and some secondary outcomes suggest that an adequately powered study is justified. Dove 2023-03-15 /pmc/articles/PMC10024904/ /pubmed/36945705 http://dx.doi.org/10.2147/COPD.S393644 Text en © 2023 Levack et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Levack, William M M
Weatherall, Mark
McNaughton, Harry K
McNaughton, Amanda A
Hobman, Anna
Jones, Bernadette
Ingham, Tristram R
Fingleton, James
Taking Charge After Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Randomized Controlled Feasibility Trial of a Psychologically Informed Self-Management Intervention
title Taking Charge After Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Randomized Controlled Feasibility Trial of a Psychologically Informed Self-Management Intervention
title_full Taking Charge After Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Randomized Controlled Feasibility Trial of a Psychologically Informed Self-Management Intervention
title_fullStr Taking Charge After Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Randomized Controlled Feasibility Trial of a Psychologically Informed Self-Management Intervention
title_full_unstemmed Taking Charge After Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Randomized Controlled Feasibility Trial of a Psychologically Informed Self-Management Intervention
title_short Taking Charge After Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Randomized Controlled Feasibility Trial of a Psychologically Informed Self-Management Intervention
title_sort taking charge after acute exacerbation of chronic obstructive pulmonary disease: a randomized controlled feasibility trial of a psychologically informed self-management intervention
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024904/
https://www.ncbi.nlm.nih.gov/pubmed/36945705
http://dx.doi.org/10.2147/COPD.S393644
work_keys_str_mv AT levackwilliammm takingchargeafteracuteexacerbationofchronicobstructivepulmonarydiseasearandomizedcontrolledfeasibilitytrialofapsychologicallyinformedselfmanagementintervention
AT weatherallmark takingchargeafteracuteexacerbationofchronicobstructivepulmonarydiseasearandomizedcontrolledfeasibilitytrialofapsychologicallyinformedselfmanagementintervention
AT mcnaughtonharryk takingchargeafteracuteexacerbationofchronicobstructivepulmonarydiseasearandomizedcontrolledfeasibilitytrialofapsychologicallyinformedselfmanagementintervention
AT mcnaughtonamandaa takingchargeafteracuteexacerbationofchronicobstructivepulmonarydiseasearandomizedcontrolledfeasibilitytrialofapsychologicallyinformedselfmanagementintervention
AT hobmananna takingchargeafteracuteexacerbationofchronicobstructivepulmonarydiseasearandomizedcontrolledfeasibilitytrialofapsychologicallyinformedselfmanagementintervention
AT jonesbernadette takingchargeafteracuteexacerbationofchronicobstructivepulmonarydiseasearandomizedcontrolledfeasibilitytrialofapsychologicallyinformedselfmanagementintervention
AT inghamtristramr takingchargeafteracuteexacerbationofchronicobstructivepulmonarydiseasearandomizedcontrolledfeasibilitytrialofapsychologicallyinformedselfmanagementintervention
AT fingletonjames takingchargeafteracuteexacerbationofchronicobstructivepulmonarydiseasearandomizedcontrolledfeasibilitytrialofapsychologicallyinformedselfmanagementintervention